Effect of medroxyprogesterone acetate on sex hormone-binding globulin mRNA expression in the human endometrial cancer cell line Ishikawa
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
Medroxyprogesterone acetate at high concentrations suppressed sex hormone-binding globulin mRNA expression in Ishikawa endometrial cancer cells, more effectively than other tested hormones.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
To understand the rationale of high-dose medroxyprogesterone acetate (MPA) in the treatment of well-differentiated uterine endometrial cancers, the effect of MPA on intracellular sex hormone-binding globulin (SHBG) mRNA expression in well-differentiated uterine endometrial cancer cell line Ishikawa was determined by competitive reverse transcription-polymerase chain reaction-Southern blot analysis. Estradiol-17beta (E2, 10(-8) mol/l) did not alter SHBG mRNA expression, but the addition of 10(-10) mol/l MPA increased it, while a high concentration of MPA (10(-6) to 10(-5) mol/l) with or without E2 suppressed it. Furthermore. a high dose (10(-6) mol/l) of chlormadinone acetate or danazol with or without E2 significantly suppressed its expression, while MPA was the most effective among the hormones tested. The effect of MPA and the other steroid hormone analogs on SHBG expression was not mediated via the progesterone receptor. These findings suggest that intracellular SHBG suppression might partly contribute to the abolition of the intracellular estrogen-dominant milieu, and may be involved as one of the mechanisms of the antitumoral effects of high-dose MPA on the development and growth of some well-differentiated endometrial cancer cells.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate 1990
- Levels of sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG) messenger ribonucleic acid (mRNAs) in ovarian endometriosis 1995
- [Mechanisms of the antitumor action of gestagens on endometrial cancer]. 1986
Cited by (2)
References (37)
- Levels of sex hormone-binding globulin (SHBG) and corticosteroid-binding globulin (CBG) messenger ribonucleic acid (mRNAs) in ovarian endometriosis via openalex
- [Mechanisms of the antitumor action of gestagens on endometrial cancer]. via openalex
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate via openalex
- doi:10.1016/0960-0760(93)90104-5 via openalex
- doi:10.1016/0090-8258(76)90050-0 via openalex
- doi:10.1210/jcem-64-4-825 via openalex
- doi:10.1016/0006-291x(85)91697-3 via openalex
- W414867036 via openalex
- doi:10.1055/s-2007-1004847 via openalex
- doi:10.1016/0002-9378(71)90207-9 via openalex
- doi:10.1006/abio.1976.9999 via openalex
- W2397383541 via openalex
- W2412074597 via openalex
- W2414203970 via openalex
- W2414558415 via openalex
- W2417743303 via openalex
- W2463986736 via openalex
- W3135067214 via openalex
- doi:10.1038/bjc.1987.61 via openalex
- doi:10.1177/030089169207800305 via openalex
- doi:10.1530/eje.0.1330327 via openalex
- doi:10.1016/s0002-9378(15)33275-0 via openalex
- doi:10.1016/0014-5793(87)80121-7 via openalex
- doi:10.1007/bf00257530 via openalex
- doi:10.1016/0022-4731(89)90083-6 via openalex
- doi:10.1042/bj0620315 via openalex
- doi:10.1111/j.1749-6632.1949.tb27297.x via openalex
- doi:10.1210/endo-97-4-825 via openalex
- doi:10.1006/abio.1987.9999 via openalex
- doi:10.1016/0304-4165(84)90365-9 via openalex
- doi:10.1016/0022-4731(87)90321-9 via openalex
- doi:10.1210/jcem.80.1.7829605 via openalex
- doi:10.1016/0300-9629(93)90278-c via openalex
- doi:10.1016/0960-0760(91)90303-m via openalex
- doi:10.1530/eje.0.1310623 via openalex
- doi:10.1016/0960-0760(91)90309-s via openalex
- doi:10.1016/0960-0760(95)00061-4 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-11T05:40:41.230350+00:00
License: CC0
· commercial use OK